Diabetes and endothelial dysfunction: a clinical perspective

Endocrine Reviews
J Calles-Escandon, M Cipolla

Abstract

The main etiology for mortality and a great percent of morbidity in patients with diabetes mellitus is atherosclerosis. A hypothesis for the initial lesion of atherosclerosis is endothelial dysfunction, defined pragmatically as changes in the concentration of the chemical messengers produced by the endothelial cell and/or by blunting of the nitric oxide-dependent vasodilatory response to acetylcholine or hyperemia. Endothelial dysfunction has been documented in patients with diabetes and in individuals with insulin resistance or at high risk for developing type 2 diabetes. Factors associated with endothelial dysfunction in diabetes include activation of protein kinase C, overexpression of growth factors and/or cytokines, and oxidative stress. Several therapeutic interventions have been tested in clinical trials aimed at improving endothelial function in patients with diabetes. Insulin sensitizers may have a beneficial effect in the short term, but the virtual absence of trials with cardiovascular end-points preclude any definitive conclusion. Two trials offer optimism that treatment with ACE inhibitors may have a positive impact on the progression of atherosclerosis. Although widely used, the effect of hypolipidemic agents on e...Continue Reading

References

Sep 24, 1992·The American Journal of Cardiology·E Bassenge, J Zanzinger
Apr 1, 1992·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·P VallanceJ Collier
Jan 1, 1992·British Journal of Clinical Pharmacology·E Bassenge
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D J Schneider, B E Sobel
Sep 3, 1991·Klinische Wochenschrift·T F Lüscher, H A Bock
Dec 1, 1991·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·M CampaniniA Monteverde
Jan 1, 1991·The Journal of Clinical Investigation·B A WolfJ Turk
Jun 1, 1991·Mayo Clinic Proceedings·J J Sixma, P G de Groot
May 1, 1990·Hypertension·T F Lüscher
Jan 1, 1990·Biorheology·J L WautierM P Wautier
Jan 1, 1990·General Pharmacology·J Marín, C F Sánchez-Ferrer
Jan 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J AuwerxJ Geboers
Apr 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·G C VibertiM J Wiseman
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T S LeeG L King
Sep 1, 1986·Diabetic Medicine : a Journal of the British Diabetic Association·M J ToopA H Barnett
Jan 1, 1986·The Journal of Clinical Investigation·M LorenziA Barrieux
Aug 1, 1983·Journal of Clinical Pathology·P R StuddyR Bird
Apr 1, 1983·The Journal of Clinical Investigation·G L KingL I Rand
Oct 15, 1983·International Journal of Cancer. Journal International Du Cancer·I A RamshawP Badenoch-Jones
May 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M RichardsonM I Cybulsky
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·J V Mombouli, P M Vanhoutte
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T YamamotoW A Border

❮ Previous
Next ❯

Citations

Feb 27, 2010·Reviews in Endocrine & Metabolic Disorders·Corey E TabitJoseph A Vita
May 10, 2002·The American Journal of Pathology·James T Rosenbaum
Mar 28, 2012·International Journal of Obesity : Journal of the International Association for the Study of Obesity·L FanK L Grove
Nov 26, 2010·The Journal of Biological Chemistry·Xiaochao WeiClay F Semenkovich
Jun 8, 2012·Diabetes Technology & Therapeutics·Irl B Hirsch, Kevin D O'Brien
May 11, 2012·American Journal of Physiology. Cell Physiology·Clintoria R WilliamsC Michael Hart
Jan 21, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·An HuangDong Sun
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Aug 2, 2011·Experimental Diabetes Research·S LiatisN Tentolouris
Mar 9, 2010·Diabetology & Metabolic Syndrome·Maria Eliane C MagalhãesSaulo Cavalcanti
Feb 26, 2011·Environmental Health Perspectives·Stacey E AlexeeffJoel Schwartz
Feb 3, 2011·World Journal of Cardiology·Xue GaoCuihua Zhang
Nov 20, 2013·International Journal of Biological Sciences·Peramaiyan RajendranIkuo Nishigaki
Sep 15, 2009·Environmental Health Perspectives·Tina M SaldanaDale P Sandler
Dec 17, 2008·Environmental Health Perspectives·Alexandra SchneiderRobert B Devlin
Sep 23, 2014·Cell Calcium·Agustin Guerrero-HernándezSilvia DeJesus
Jan 25, 2005·Current Diabetes Reports·Glenn MatfinVivian A Fonseca
Jul 18, 2003·Current Diabetes Reports·Waleed Aldhahi, Osama Hamdy
Mar 20, 2003·Current Diabetes Reports·Gary E McVeigh, Jay N Cohn
Nov 23, 2006·Current Diabetes Reports·Eberhard Ritz
Aug 2, 2006·Current Diabetes Reports·Christopher J LockhartJay N Cohn
Jun 17, 2009·Seminars in Reproductive Medicine·Rhonda Bentley-Lewis
Feb 23, 2013·Diabetes Care·M Kamran IkramUNKNOWN NIH/JDRF Workshop on Retinal Biomarker for Diabetes Group
Jan 1, 2003·Current Neurology and Neuroscience Reports·Harold P Adams
Sep 5, 2008·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Erick AlexandersonGraciela Alexanderson
Jan 22, 2005·Diabetologia·D TaubertE Schömig
Apr 17, 2013·Reviews in Endocrine & Metabolic Disorders·Tetsuya KubotaTakashi Kadowaki
Nov 6, 2003·Sports Medicine·Andrew MaioranaDaniel Green

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2021 Meta ULC. All rights reserved